ObsEva’s Oral Treatment for Uterine Fibroids Nails Phase III
An oral drug developed by the Swiss company ObsEva was shown to reduce menstrual bleeding…
December 10, 2019 - 2 minutes
ObsEva
Successful Phase III Results for Swiss Biotech ObsEva’s Drug for In Vitro Pregnancy
Yesterday, Swiss biotech ObsEva highlighted positive Phase III results that show their fertility treatment nolasiban…
February 27, 2018 - 2 minutes
Meet the Gynecologist at the Helm of Geneva’s Star Biotech
Ernest Loumaye began as a doctor at a university hospital and is now CEO of…
June 26, 2017 - 5 minutes
In Geneva, the Capital of Peace, 10 Biotechs Are Putting up a Fight
Geneva is the largest city in French-speaking Switzerland, a financial powerhouse, home to the United…
May 30, 2017 - 7 minutes
UPDATE: Reproductive Health Biotech starts Phase III after €90M IPO
UPDATE (07/03/2017): ObsEva has announced the start of its Phase III trials for nolasiban, an oral…
March 7, 2017 - 3 minutes
